Sep
Neuroscience Talk: The therapeutic potential of complement C3a receptor agonists in the post-acute phase after stroke
"The therapeutic potential of complement C3a receptor agonists in the post-acute phase after stroke”
Marcela Pekna, MD, PhD, Professor
Laboratory of Regenerative Neuroimmunology, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the Univ. of Gothenburg, Sweden
Prof. Marcela Pekna heads the Regenerative Immunology research group at the Institute of Neuroscience and Physiology, Gothenburg University. Marcela and her group are carrying out pioneering investigations on how the complement system regulates repair versus damage upon ischemic injuries or neurodegenerative disease (particularly ALS).
The complement was traditionally considered as a system of plasma proteins that react with one another to opsonise pathogens and help fight infections. However, it turns out that brain cells (and particularly glia) also express these proteins, which orchestrate a number of physiopathological responses playing both protective and pro-inflammatory roles.
Lecture host: Professor Angela Cenci Nilsson
About the event
Location:
room E11075, BMC
Contact:
diana [dot] jerman [at] med [dot] lu [dot] se